Single-beat estimation of end-diastolic pressure-volume relationship: a novel method with potential for noninvasive application THE LEFT VENTRICULAR (LV) end-diastolic pressure-volume relationship (EDPVR) is the most important means of characterizing passive ventricular properties, in that it is the global, integrated expression of chamber geometry, wall thickness, and all aspects of passive material properties of the myocardial wall. By definition, the EDPVR indicates the amount of diastolic filling that will occur for a specified filling pressure and is therefore a key physiological determinant of preload (10, 13) . In addition, assessment of this relationship is fundamental to the study of the pathophysiology of ventricular remodeling in heart failure and in response to surgical, pharmacological, or device-based treatment strategies (8, 11, 14, 21) .
Most studies of the EDPVR have been undertaken in ex vivo models of either beating or arrested hearts in which a balloon is placed in the LV chamber and volume is varied while pressure is measured (5, 12, 22) . In vivo assessment of the EDPVR requires use of a means of continuous volume measurement, such as a conductance catheter or multidimensional sonomicrometry, during transient inferior vena caval occlusion (IVCO) (1, 2, 15) . For human subjects, the conductance catheter technique is the only feasible volume measurement technique for this purpose. However, required use of invasive techniques to assess the EDPVR has limited its clinical utility in patients.
Until recently, measurement of the end-systolic pressurevolume relationship (ESPVR) also required continuous invasive pressure-volume measurements over a range of volumes created by IVCO. However, Sunagawa and colleagues (25) and Kass and colleagues (7, 24) suggested means of estimating the entire ESPVR from measurement of pressure-volume data from a single beat. Kass and colleagues developed and validated a noninvasive approach in patients from measurements of blood pressure (sphymometry), ventricular volumes (e.g., echocardiography, radionucleotide ventriculography), and Doppler-derived measurements of specific time intervals of the cardiac cycle (7, 24) . Such approaches have the potential to overcome the obstacles that have impeded more widespread use of the pressure-volume approach in studies of ventricular mechanics in health and disease. Availability of a comparable approach for assessing the EDPVR would be another major step toward achieving this goal.
We obtained ex vivo EDPVRs from normal and diseased human hearts having a very wide range of heart sizes. We derived an algorithm for normalizing ventricular volume that yielded volume-normalized EDPVRs from all hearts that were very similar to each other. This indicated the existence of a common underlying shape of the EDPVR, independent of heart condition, which can be expressed by a simple analytical expression. This same equation was also shown to be relevant for hearts of normal and diseased animals. It is demonstrated how this analytical equation yields a strategy for predicting the whole EDPVR from a single end-diastolic pressure-volume point. Finally, this approach was validated using the data obtained from in vivo normal and failing hearts of humans, dogs, and rats.
METHODS

Human Heart Harvest and Ex Vivo Pressure-Volume Relationships
Eighty freshly harvested human hearts were obtained for the study. Hearts were from five normal subjects not suitable for transplantation, 23 transplant patients with ischemic cardiomyopathy, 30 transplant patients with idiopathic cardiomyopathy, and 22 patients with endstage cardiomyopathy supported with an LV assist device (LVAD, TCI HeartMate, Thoratec, Pleasanton, CA, average length of support, 114 Ϯ 86 days). All hearts were perfused with cold hypocalcemic, hyperkalemic cardioplegia solution at explant. The passive LV pressure-volume relationship of each arrested heart was measured as described previously with an intraventricular balloon (4).
In Vivo Human Experiments
Single-beat estimation of EDPVR was tested by using in vivo human data from 10 healthy old and 13 healthy young controls and from 13 patients with heart failure and a normal ejection fraction (HFNEF). The in vivo EDPVRs were constructed by conductance catheter technique using transient inferior vena caval occlusion as described in detail previously (7, 20, 24) .
In Vivo Canine Experiments
Data were also obtained from 12 open chest dogs and from 14 chronically instrumented awake dogs. In the chronically instrumented dogs, data were available from each dog under normal conditions and following induction of heart failure by repeated coronary embolization (23) .
For acute experiments, LV pressure (LVP) was measured by a catheter tip micromanometer (Millar, Houston, TX) placed inside the LV from the right or left carotid artery. A plastic balloon occluder was placed around the inferior vena cava for temporary occlusion (IVCO). Six ultrasound crystals were positioned in the midmyocardium (3 pairs to measure anterior-to-posterior, base-to-apex and septum-tolateral wall distances) to estimate LV volume (LVV) based on an ellipsoidal model: LVV ϭ /6(a ⅐ b ⅐ c), where a, b, and c are the principle axis dimensions.
For chronic experiments, animals were instrumented with an indwelling pressure gauge (Konigsberg), sonomicrometer crystals, and an balloon occluder around the inferior vena cava as described previously (28) . LVV was obtained the same way as in acute experiments. Measurements of EDPVRs were obtained in a conscious state of the animal by transient IVCO at baseline and 4 wk after induction of heart failure by repeated, daily intracoronary microsphere embolization.
Ex Vivo and In Vivo Rat Experiments
Data were also obtained from Sprague-Dawley rats in heart failure 6 and 12 wk after coronary artery ligation (n ϭ 58) and in 22 normal control rats. For in vivo assessment of the LV passive pressurevolume characteristics, the rats were intubated after induction of anesthesia with isoflurane, and the right carotid artery was cannulated with a Millar conductance catheter (Millar Instruments, Houston, TX). LV EDPVRs were performed by temporary IVCO. For ex vivo assessment of the LV passive pressure-volume characteristics, the heart was arrested in diastole and excised quickly. The left atrium was opened, and a thin latex balloon was attached to the end of a 10-cm length of stiff polyethylene tubing with fenestrations at the distal 3 mm of its tip. LVP was measured using a 5-Fr Millar micromanometer as volume was infused into the balloon at 0.025-ml increments.
All (17) . This suggests that EDPVRs share a common underlying shape and that, if appropriately scaled using a single descriptive equation, the curves may converge. To test this hypothesis, ex vivo EDPVRs from humans were normalized (EDPVR n) in the volume dimension to account for the unstressed volume (V0, volume at which EDP is ϳ0 mmHg) and V30, the volume at which EDP equals 30 mmHg, according to the following equation:
The resulting EDPVRns obtained from the experiments outlined above were superimposed to visually determine their degree of similarity. After having established qualitatively that indeed a relatively high degree of similarity exists among these normalized curves, we proposed that the ex vivo EDPVR ns from different groups (human, canine, and rat hearts) could be described by a function with a single universal set of parameter values (An, Bn) for the function:
which optimally describe the data (least-square method using commercially available software; IgorPro 4.1, WaveMatrics, Lake Oswego, OR).
Single-beat approach to predicting EDPVR. As will be shown, data indicated the EDPVR ns were similar from ex vivo human, dog, and rat hearts, and curve fitting yielded essentially the same values for An and Bn in the different species, indicating a common underlying shape of the EDPVR. From this observation, it is possible to predict the entire EDPVR from a single point on the curve as detailed forthwith.
The procedure starts with measurement of EDP and EDV on a single beat (P m, Vm, respectively). Based on Eq. 1, normalized measured volume (Vm,n) is defined as follows:
The resulting V m,n-Pm point would fall on the curve:
Solving Eq. 4 for V m,n, substituting the result into Eq. 3, and solving for V30 yields:
To predict the EDPVR, a reasonable estimate of V 0 is required. The relative constancy of the shape of the normalized EDPVR further suggested a relatively consistent relationship between the volume at a certain pressure and V 0. To test this, we determined the volumes from each human ex vivo heart that provided pressures of 10, 15, 20, and 25 mmHg. These volumes designated V10, V15, V20, and V25, respectively, were each separately plotted versus the V0 determined from each measured EDPVR (Fig. 1) . For each plot, we determined the linear regression equation forced through the origin:
The value of k obtained at each pressure level was then plotted as a function of P m, and linear regression analysis was applied with the following result: 
Substitution of Eq. 7 into Eq. 6 yields:
The entire EDPVR of an individual heart can then be predicted from analytical determination of ␣ and ␤ to force the curve through the measured point on the EDPVR and the predicted V0 (Eq. 8) and V30 (Eq. 5) according to the following:
Thus the final sequence of calculations from a single set of Pm and Vm values would be: 1) calculate V0 from Eq. 8; 2) calculate V30 from Eq. 5; 3) calculate ␣ and ␤ from Eqs. 9 and 10; and 4) use these estimates of ␣ and ␤ to specify the entire EDPVR by:
To test this approach, half of the ex vivo human EDPVRs (group 1) chosen at random were used to determine optimal values for An and Bn. The predictive power was then tested on the remaining ex vivo human EDPVRs (group 2). The approach was then further tested prospectively by using data obtained from in vivo human and canine and ex vivo and in vivo rat studies, again using the A n and Bn values obtained from group 1 ex vivo human hearts.
Statistical Methods
Results are expressed as means Ϯ SD. Root-mean-square error (RMSE) between measured and predicted pressures over the entire EDPVR was calculated for each heart as [¥(Pm Ϫ Pp) 2 ] 1/2 with the summation performed over each measured pressure-volume point. One-way ANOVA was used to detect significant differences in RMSE values among the different groups of hearts (ex vivo and in vivo human hearts, acute dog experiments, chronic dog experiments, and ex vivo and in vivo rat hearts). Dunn's test was used for post hoc multiple comparison. Analyses were performed using commercially available software (SPSS 11.5, Chicago, IL).
RESULTS
Ex Vivo Human Heart Results
Representative examples of EDPVRs measured from ex vivo human hearts are shown in Fig. 2A . As shown in these examples, EDPVRs from different types of hearts (normal, idiopathic dilated cardiomyopathy, ischemic cardiomyopathy, post-LVAD) spanned very wide ranges of volumes. Some hearts reached filling pressures of 30 mmHg at as little as ϳ80 ml, and others reached this same pressure at more than 300 ml. These same EDPVRs are shown in Fig. 2B after volume was normalized according to Eq. 3. These curves reveal a high degree of concordance between hearts in these different states. Figure 3 shows data from all 80 human EDPVR n s superimposed on each other. As shown, there is relatively little deviation of these normalized data around a common curve. Optimal A n and B n values (ϮSD) obtained from the group as a whole were 27.8 Ϯ 0.3 and 2.76 Ϯ 0.05, respectively. Furthermore, although the amount of data available from normal hearts is fairly limited, A n and B n were similar between normal and cardiomyopathic hearts (P Ͼ 0.7).
Optimal A n and B n from a randomly selected subset of 40 of the ex vivo human hearts (designated as group 1) were 28.2 and 2.79 mmHg, respectively, which where very similar to those obtained from the group as a whole. These parameter values were used prospectively to predict the EDPVRs in the remaining ex vivo human data (designated as group 2). Representative examples of EDPVR predictions of ex vivo data are shown in Fig. 4, A-D square shows an end-diastolic pressure-volume point at an EDP of ϳ15 mmHg selected for the test (i.e., these are P m and V m for Eqs. 9 and 10). The dotted line shows the curve fit from the raw data using a nonlinear analytic expression (EDP ϭ P 0 ϩ ␣⅐EDV ␤ ). The solid line shows the EDPVR predicted from Eqs. 9, 10, and 11. The average RMSE between measured and predicted EDPVRs from the 40 hearts used for the test was 1.74 Ϯ 1.2 mmHg. Figure 4 , A and B, shows examples for which the RMSE between measured and predicted EDPVRs was close to the average for the overall group; these results, which are indicative of the average results, reveal a good predictive capability of the approach. Note in these two examples that the predicted V 30 point is very close to the measured value. Figure 4C shows an example with a very low RMSE value (0.51 mmHg, among the best predictions), whereas Fig.  4D shows an example with one of the highest RMSE values (5.70 mmHg, among the worst predictions). Interestingly, we did not find any differences in the predictive capability of this approach among the different types of hearts studied (i.e., chronic heart failure, post-LVAD, or normal control hearts).
The overall accuracy of this approach to predict V 0 (Eq. 8) and V 30 (Eq. 5) is summarized in Fig. 5 and Table 1 for group 2 ex vivo human hearts (Fig. 5A ) and for hearts of other settings (Fig. 5B) . As shown, the measured versus predicted V 0 and V 30 We next explored whether the accuracy of the EDPVR prediction depended on the range within which the measured end-diastolic pressure point falls. RMSE between measured and predicted EDPVRs were obtained from all ex vivo EDPVRs at different pressure points (ϳ10, ϳ15, and ϳ20 mmHg). Figure 6 shows that when a measured pressurevolume point having an EDP above 15 mmHg is used to predict the EDPVR, the prediction is better than when it is predicted by a point having an EDP of 10 mmHg or less (P Ͻ 0.05 10 mmHg vs. 15 and 20 mmHg).
In Vivo Human Hearts
EDPVRs were measured from 36 human hearts in vivo by using the conductance catheter technique of volume measurement and transient IVCO to reduce preload. The EDP-EDV from the starting loop (i.e., before IVCO) were the designated P m and V m values for EDPVR prediction. Overall, the average RMSE obtained from the 36 EDPVRs was 2.99 Ϯ 1.72 mmHg. Four examples (two average, one above average, and one of the worst examples) are shown in Fig. 7, A-D , respectively. The example showing the worst predictive value (Fig. 7D) was from a patient with heart failure with normal ejection fraction (HFNEF) in which the EDPVR did not have an asymptote with the x-axis, which was considered to be because of high rightsided filling pressures and pericardial mediate interventricular interactions. Another means of assessing the accuracy of the prediction was to compare measured and predicted pressures at an intermediate volume, e.g., at a volume yielding 15 or 20 mmHg, V 15 and V 20 , respectively. For these in vivo human hearts, measured versus predicted V 15 was 113 Ϯ 27 vs. 110 Ϯ ajpheart.physiology.org 27 ml, and for V 20 these numbers were 120 Ϯ 28 vs. 115 Ϯ 29, differences of only 3-5 ml or less than a 5% error.
Other Species
To explore the overall general applicability of this approach, data from acute and chronic in vivo dog hearts and in vivo and ex vivo rat hearts were also explored. Plots comparable to those of Fig. 3 revealed similar behavior in each of these settings and, remarkably, the parameter values for A n and B n were nearly identical to those identified in the ex vivo human hearts (Table 1) . Also shown in Table 1 , the means Ϯ SD RMSE values between measured and predicted EDPVRs and the regression coefficients for the relationship between measured and predicted V 30 values for all groups were also, in general, comparable among these different settings so that prospective EDPVR predictions (Fig. 8) were generally excellent. The RMSE values for in vivo human and chronic dog hearts were slightly higher than those attained in the other settings, but the values were still relatively small, indicating good prospective predictive capability of this approach.
Sensitivity Analysis
It is pertinent to ask about the sensitivity of the predicted curves to potential inaccuracies in measurement of pressures and volumes, particularly for the clinical scenario when both parameters may be measured noninvasively. Of course, any technique for measuring the EDPVR is equally sensitive to the methods used to measure both pressure and volume. Such an analysis is relatively straightforward because of the simple analytical nature of the prediction algorithm, therefore, for the sake of brevity, only two important examples involving errors in P m variation are considered in this section; a similar analysis of error in V m yields similar findings. Figure 9 shows EDPVRs predicted from a common V m of 100 ml and P m values of 16 mmHg along with P m values of 14 and 18 mmHg and 13 and 19 mmHg (i.e., 16 Ϯ 2 and 16 Ϯ 3 mmHg). As seen, the impact is relatively minor if one were interested in determining Next consider the potentially more difficult example in which data from groups of normal and heart failure patients may be compared. In such a case, P m may be in the range of 12 mmHg and V m in the range of 100 ml in the normal group and 24 mmHg and 225 ml, respectively, in a group of patients with heart failure due to systolic dysfunction. Figure 9B shows predicted EDPVRs at these values of V m and P m along with those obtained with P m values Ϯ3 mmHg. The graphs show that even with errors of this magnitude and despite performing estimates from different pressure ranges, information regarding the EDPVR is relatively consistent. More specifically, in the heart failure state, the value of capacitance (volume at a given pressure) is influenced similarly in the simulated failing and normal states (except in the low pressure range). However, the shape of the EDPVR (which would relate more directly to an estimate of chamber compliance and stiffness) is more significantly influenced in the heart failure state, especially in the low pressure range.
Another important aspect of the prediction algorithm is the estimation of V 0 using Eq. 8, which can be associated with significant uncertainty and inaccuracy especially as the volume of the heart increase as in systolic heart failure. Figure 9C shows a hypothetical example with an assumed V m of 200 ml at a P m of 10 mmHg. Equation 9 predicts a V 0 of 108, but based on Fig. 1 , V 0 could exhibit considerable variability. The three graphs of Fig. 9C show EDPVR predictions with V 0 values of 75, 100, and 125 ml. Despite this rather large variation in the assumed V 0 value, the impact on predicted EDPVR is relatively mild.
DISCUSSION
We developed and tested a novel method for estimating the EDPVR from a single end-diastolic pressure-volume point. From the availability of Doppler-echocardiography (6, 18) , radionuclide ventriculography (3, 27), and magnetic resonance (9) imaging methods to estimate ventricular pressures and volumes, this approach to EDPVR estimation has the possibility of being utilized noninvasively. Interestingly, though developed primarily based on data from human hearts, the approach appears to be generally applicable to normal and diseased hearts of different species. Values of RMSE ranging between 0.5 and 6 mmHg among all these hearts (Table 1) indicate that, on average, the predicted EDPVR falls within 1.8 mmHg of the actual EDPVR over a range of conditions.
The proposed single-beat EDPVR estimation method is based on the premise that the end-diastolic pressure-volume relation can generally be described by common nonlinear analytical expressions with coefficient values that are reasonably well linked with the size of the heart (17). This suggests that overall these EDPVRs share a common underlying shape. The present results are intended to facilitate the use of the EDPVR in clinical and research settings where assessment of changes in passive ventricular properties are important, such as in certain disease states and following therapeutic interventions. The prospective prediction of EDPVRs measured in vivo using the conductance catheter technique combined with transient inferior vena caval occlusion serve as important validation of the approach.
The low RMSE values between measured and predicted EDPVRs indicate good predictive accuracy of the approach. The accuracy was greatest when the pressure of the single measured end-diastolic pressure-volume point existed within a pressure range over 15 mmHg. Specifically with regard to the clinical situation, this single-beat approach provided a predicted EDPVR that was on average within ϳ3 mmHg of that measured in humans using the conductance technique.
Taken to the extreme, the underlying assumption that the EDPVR of all hearts share a common underlying shape regardless of species or disease state would lead to the conclusions that passive myocardial properties and chamber geometry change in only one way and that any two hearts that have a single common end-diastolic pressure-volume point would have identical EDPVRs. However, consider even the extreme case shown in Fig. 4D . In this example, measured and predicted values of ␣ and ␤ are considerably different. Despite such deviations, which reflect expected variations in material properties and geometry, the differences between the actual and predicted EDPVRs are relatively small. The average results indicate that the expected deviation between predicted and measured EDPVR curves is typically Ͻ3 mmHg. Nevertheless, this means that results obtained using the proposed approach would be most accurate when applied to groups of hearts (where such deviations would average out), rather than to individual hearts.
To illustrate this point, consider the example shown in Fig.  10 . Little et al. (16) provided group-average end-diastolic pressure-volume data in Table 1 of their publication. These data were obtained in an experimental canine preparation in which volumes were measured by sonomicrometry and pressure measured by a solid-state transducer over a range of conditions achieved by phenylephrine administration. These data, which are rarely provided in published papers, were plotted and the EDPVR predicted using the proposed approach. This completely independent data suggest that the proposed approach is reasonable. We propose that one potentially important use of this approach is in a research setting in which group-averaged EDPVRs from different groups are to be estimated and compared.
Several prior studies have reported methods for single-beat estimation of the end-systolic pressure-volume relationship (ESPVR) with good predictions of end-systolic elastance (7, 24, 26) . The linearity of the ESPVR simplifies in some ways its prediction. The inherent nonlinearity of the EDPVR makes its prediction with a single beat approach more difficult. However, the common shape of this curve and uniformity following In practice, the proposed scheme for predicting the EDPVR can be accomplished noninvasively. Methods for measurement of LV volume include magnetic resonance imaging, threedimensional echocardiography, and radionuclide ventriculography (3, 29, 30) . Measurement of pulmonary vein velocity by Doppler-echocardiographic techniques provides a means of estimating LV EDP (19) .
Study Limitations
The correlation between predicted and measured points was excellent in all ex vivo setups and in vivo acute dogs and rats, measured with sonomicrometry and conductance techniques, respectively. These experimental settings offer ideal conditions in which confounding factors (e.g., controlling respiration) are minimized, and the ability to vary volumes and pressures over a broad range is possible. The good, but slightly lower, correlation obtained from in vivo chronic conscious dog and human data may reflect the effects of respiration and possibly effects of interventricular interactions and pericardial constraints, which may result in an EDPVR that does not have an asymptote with the volume axis (as in Fig. 7D ). However, these factors did not impair the ability of the overall approach to provide good predictions in a majority of cases. Such factors could become more important in disease states where right ventricular overload is more prominent and thus limit the utility of the present approach.
The values of A n and B n were obtained from normal and dilated cardiomyopathic hearts, which may limit the applicability of the approach to other disease states. Nevertheless, the approach appeared to apply well in vivo to patients even with heart failure and normal ejection fraction due to hypertensive and/or idiopathic hypertrophic cardiomyopathies. This again speaks to the general applicability of the underlying observation that the EDPVR generally has a common shape.
The mathematical form of the equation used to describe the EDPVR (P ϭ ␣V ␤ ) was chosen because it was the only one of the commonly used equations that lends itself to the analytical solution permitting the current prediction. However, it is cur- (16) were replotted and EDPVR predicted using the proposed method. Prediction (line) matches this group-averaged data (from a completely independent source) quite satisfactorily. rently more common that an exponential equation be used to describe the EDPVR (e.g., P ϭ ␣e ␤V ). Thus the values of ␣ and ␤ generated using the present approach will differ from those now commonly appearing in the literature. For example, typical values for ␣ and ␤ obtained with the present approach would be 1.6 ϫ 10 Ϫ11 mmHg and 6.0, respectively, for normal human hearts and 4.1 ϫ 10 Ϫ9 mmHg and 5.8, respectively, for normal dog hearts.
From an analytical perspective, the prediction also depends on a degree of difference between the P m and 30 mmHg. Thus, for P m between ϳ27 and 32 mmHg, the currect predictions break down. Future efforts could also resolve this limitation.
Finally, further consideration should be given to the effects of right-sided filling pressures, pericardial pressures, and ventricular interdependence. This is especially important in the data generated by caval occlusion in which these pressures are changing and can influence the resulting EDPVR. Whereas such effects can be eliminated in studies performed ex vivo (i.e., by completely unloading the RV), these effects are difficult (sometimes impossible) to discern in vivo without the use of special instrumentation (e.g., pericardial pressure measurements). Thus, even when measured invasively with a conductance catheter or by sonomicrometry, interpretation of an EDPVR measured in vivo during caval occlusion is subject to these same limitations.
In addition to potentially addressing these limitations, future efforts could possibly improve the proposed approach. The cornerstone of such efforts should be aimed at obtaining a larger amount of invasive data from human and animal hearts over a range of normal and pathophysiological states. Such data could be used to refine the parameters employed in the prediction method. Among the parameters that could possibly be refined would be those used in the prediction of V 0 in different settings and an attempt to understand the degree to which actually allowing disease-specific differences in the shape of the EDPVR could improve predictive accuracy.
In conclusion, the LV end-diastolic pressure-volume relationship can be reasonably estimated from a single pressurevolume point, and the predicted relationships are generally well correlated with directly measured data. The results obtained are most accurate when applied to groups of hearts rather than to individual hearts. The potential for noninvasive application is particularly appealing and is complementary to the recently proposed approach to single beat estimation of the ESPVR.
